Agenus
AGEN
₹424.46
Share price
5.21%
Change (1 day)
-64.47%
Change (1 year)
Categories
Earnings for Agenus (AGEN)
Earnings in 2025 (TTM): -₹7.96 Billion
According to Agenus 's latest financial reports the company's current earnings are ₹99.52 Million. In 2024 the company made an earning of -₹9.85 Billion, an increase over its 2023 earnings that were of -₹13.7 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Agenus from 2000 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -₹7.96 Billion | -19.12% |
| 2024 | -₹9.85 Billion | -28.13% |
| 2023 | -₹13.7 Billion | -5.5% |
| 2022 | -₹14.49 Billion | -556.26% |
| 2021 | ₹3.17 B | -130.37% |
| 2020 | -₹10.46 Billion | 73.75% |
| 2019 | -₹6.02 Billion | -48.74% |
| 2018 | -₹11.75 Billion | 34.32% |
| 2017 | -₹8.75 Billion | -7.16% |
| 2016 | -₹9.42 Billion | 26.55% |
| 2015 | -₹7.44 Billion | 110.24% |
| 2014 | -₹3.54 Billion | 49.12% |
| 2013 | -₹2.38 Billion | |
| 2011 | -₹1.64 Billion | -12.25% |
| 2010 | -₹1.87 Billion | -21.41% |
| 2009 | -₹2.38 Billion | -26.86% |
| 2008 | -₹3.25 Billion | 13.72% |
| 2007 | -₹2.86 Billion | -33.4% |
| 2006 | -₹4.29 Billion | -31.84% |
| 2005 | -₹6.3 Billion | 9.74% |
| 2004 | -₹5.74 Billion | -0.8% |
| 2003 | -₹5.79 Billion | 17.37% |
| 2002 | -₹4.93 Billion | 37.83% |
| 2001 | -₹3.58 Billion | 55.99% |
| 2000 | -₹2.3 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Merck MRK | ₹1.841 T | -22,862.97% | 🇺🇸 USA |
 GlaxoSmithKline GSK | ₹464.47 B | -5,842.33% | 🇬🇧 UK |
 Johnson & Johnson JNJ | ₹2.352 T | -29,185.66% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -₹18.65 Billion | 130.50% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | ₹524.29 B | -6,581.87% | 🇺🇸 USA |